Genome Medicine (Sep 2020)

A polyclonal allelic expression assay for detecting regulatory effects of transcript variants

  • Margot Brandt,
  • Alper Gokden,
  • Marcello Ziosi,
  • Tuuli Lappalainen

DOI
https://doi.org/10.1186/s13073-020-00777-8
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 10

Abstract

Read online

Abstract We present an assay to experimentally test the regulatory effects of genetic variants within transcripts using CRISPR/Cas9 followed by targeted sequencing. We applied the assay to 32 premature stop-gained variants across the genome and in two Mendelian disease genes, 33 putative causal variants of eQTLs, and 62 control variants in HEK293T cells, replicating a subset of variants in HeLa cells. We detected significant effects in the expected direction (in 60% of variants), demonstrating the ability of the assay to capture regulatory effects of eQTL variants and nonsense-mediated decay triggered by premature stop-gained variants. The results suggest a utility for validating transcript-level effects of genetic variants.

Keywords